Alzheimer's disease diagnosis and management: Perspectives from around the world
Year: 2022
Type: article
Abstract: Alzheimer's disease (AD) and other dementias are a global challenge. Early diagnosis is important to manage the disease. However, there are barriers to diagnosis that differ by region. Researchers from Brazil, China, Nigeria, Spain, and Sweden have identified key barriers to AD diagnosis in their countries. In Brazil, socioeconomic inequalities and poor recognition of dementia by physicians can prevent diagnosis. In China, a very large population and lack of physician training in dementia make diagnosis problematic. In Nigeria, socioeconomic inequalities and cultural stigma can stand in the way of diagnosis. In Spain, patient hesitancy and an overloaded health-care system are barriers to diagnosis. In Sweden, inconsistent use of biomarkers is a prominent barrier to diagnosis of AD. To support diagnosis, more focus is needed on education of patients and physicians, increased use of support services, and improved access to biomarkers to accurately diagnose AD.
DOI: 10.1002/dad2.12334
Institutions: Instituto de Salud Carlos III, Universitat Internacional de Catalunya, Biomedical Research Networking Center on Neurodegenerative Diseases, Universidade Federal de Minas Gerais, University of Ibadan, University College Hospital, Ibadan, Cleveland Clinic, Lou Ruvo Brain Institute, Sahlgrenska University Hospital, UK Dementia Research Institute, UCL Queen Square Institute of Neurology, University College London, University of Gothenburg, F. Hoffmann-La Roche AG
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,200
OpenAlex ID: W4286821205
